| Repeat dosing of hypoimmunogenic cells |
2022-10-25 |
2022-12-01 |
|
| Hypoimmunogenic neural cells for the treatment of neurological disorders and … |
2022-9-20 |
2022-11-01 |
|
| Targeted lipid particles and compositions and uses thereof |
2022-9-19 |
2022-11-01 |
|
| Inducible systems for altering gene expression in hypoimmunogenic cells |
2022-8-11 |
2023-2-16 |
|
| Genetically modified cells for allogeneic cell therapy to reduce instant blood … |
2022-8-11 |
2023-3-23 |
|
| Engineering cells for cell-based therapies, and associated compositions and … |
2022-8-11 |
2023-2-16 |
|
| Genetically modified cells for allogeneic cell therapy to reduce complement- … |
2022-8-11 |
2023-2-16 |
|
| Genetically modified primary cells for allogeneic cell therapy |
2022-8-11 |
2023-2-16 |
|
| Genetically modified cells for allogeneic cell therapy |
2022-8-11 |
2023-2-16 |
|
| Use of cd4-targeted viral vectors |
2022-8-03 |
2023-2-09 |
|
| Polycistronic vectors for cell-based therapies |
2022-7-18 |
2023-1-19 |
|
| Safety switches for regulation of gene expression |
2022-7-17 |
2022-9-01 |
|
| Altered expression of y chromosome-linked antigens in hypoimmunogenic cells |
2022-7-12 |
2023-1-19 |
|
| Cryogenic storage racks and associated systems, devices, and methods |
2022-7-07 |
2023-1-19 |
|
| Cryogenic cassettes and associated systems, devices, and methods |
2022-6-22 |
2022-12-29 |
|
| Lipid particles containing a truncated baboon endogenous retrovirus (baev) … |
2022-5-27 |
2022-12-01 |
|
| Hypoimmunogenic cells comprising engineered hla-e or hla-g |
2022-5-25 |
2022-12-01 |
|
| Hypoimmunogenic rhd negative primary t cells |
2022-5-20 |
2023-3-02 |
|
| Cd8-specific antibody constructs and compositions thereof |
2022-4-07 |
2022-10-20 |
|
| Immunosuppressive therapies for use with cardiomyocyte cell therapies, and … |
2022-3-02 |
2022-9-09 |
|
| Methods and compositions for modulating car-t activity |
2022-2-07 |
2022-7-21 |
|
| Use of cd8-targeted viral vectors |
2022-1-10 |
2022-7-14 |
|
| Hepatocyte-like cells |
2021-10-13 |
2022-4-21 |
|
| Methods for triggering safety killing mechanisms using a cd47-sirpĪ± blockade … |
2021-10-12 |
2022-8-01 |
|
| Modified anti-viral binding agents |
2021-8-30 |
2022-3-03 |
|
| Methods of treating sensitized patients with hypoimmunogenic cells, and … |
2021-8-13 |
2022-7-16 |
|
| Methods and compositions for treatment of viral infections |
2021-5-19 |
2021-11-25 |
|
| Repeat dosing of low immunogenic cells |
2021-4-27 |
2023-4-04 |
|
| Modification of blood type antigens |
2021-1-12 |
2021-7-22 |
|
| Cd24-associated particles and related methods and uses thereof |
2020-9-02 |
2022-7-13 |
|
| Cd24 expressing cells and uses thereof |
2020-8-24 |
2021-3-04 |
|
| Dux4 expressing cells and uses thereof |
2020-7-31 |
2022-6-08 |
|
| Viable prebiotics bacteria microcapsule preparations for livestock and method … |
2007-8-09 |
2010-1-20 |
2010-1-20 |